File(s) not publicly available
Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome
No description available
History
Publication title
Current Opinion in Investigational DrugsVolume
7Issue
11Pagination
1020-1025Department/School
Menzies Institute for Medical ResearchPlace of publication
The Thomson CorporationRepository Status
- Restricted